Biotika a.s., a biotechnology company, operates as a pharmaceutical manufacturing company in Slovakia and internationally. It offers active pharmaceutical ingredients (API), including Phenoxymethylpenicillin Potassium and Polymyxin B Sulfate. The company is also involved in the contract manufacture of APIs comprising Gramicidin S Hydrochlorid. In addition, it produces and sells cosmetic products; beverages, protein substances, and its derivatives; disinfectants and organic chemical; compost and organic fertilizer; medical devices; veterinary medicines; feed additives ; feed ingredients; freight road transportation services; rental services; rental of movable property; and retail and wholesale goods. Further, it provides waste water treatment and cooling water diversion services, as well as various services in the waste management sector; freight road transportation services; and rental services. Additionally, the company engages in the research and development of natural and technical sciences; and operation of railway track. Biotika a.s. was founded in 1953 and is headquartered in Slovenská Lupca, Slovakia.
Metrics to compare | 1BSL01AE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1BSL01AEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.4x | 17.1x | −0.6x | |
PEG Ratio | 0.02 | 0.04 | 0.00 | |
Price/Book | 0.3x | 1.6x | 2.6x | |
Price / LTM Sales | 0.4x | 3.3x | 3.4x | |
Upside (Analyst Target) | - | −4.2% | 42.5% | |
Fair Value Upside | Unlock | 6.7% | 5.8% | Unlock |